A Call to Action from the AACR and its Minorities in Cancer Research Membership Group
The American Association for Cancer Research (AACR) and its Minorities in Cancer Research (MICR) membership group today issued a...
AACR Will Build on Productive Relationship With President Biden to Advance Cancer Research
The American Association for Cancer Research (AACR) and its 47,000 member scientists and physicians are unified in a strong desire...
How Community Outreach Can Increase Access to Colorectal Cancer Screening in Underserved Populations
Like most cancers, colorectal cancer (CRC) is easier to treat before it spreads to other organs. When caught in its earliest stages, the five-year relative...
AACR Annual Meeting 2021: Week 2 Begins Monday
Week 2 of the AACR Annual Meeting 2021 kicks off Monday and will run through Friday, May 21. The first week...
ASCO-AACR Methods in Clinical Cancer Research Workshop Explores Best Practices in Clinical Trial Design
Clinical trials are a crucial part of the cancer research continuum, providing a testing ground for the safety and...
AACR Past President Leads Important Conversations on Screening, Prevention
Monday afternoon, First Lady Jill Biden visited the Medical University of South Carolina (MUSC) Hollings Cancer Center as part...
Starting the Conversation: Panel Discusses National Black Family Cancer Awareness Week
Karriem Watson is a public health expert serving as chief engagement officer of the National Institutes of Health’s All...
ICYMI: A Recap of Blog Posts From AACR Annual Meeting 2022
From a joyous opening performance from the Preservation Hall All-Stars to a closing plenary that highlighted the full spectrum...
Turning Cancer Disparities Research Into Action
In 2008, Robin Evans received a devastating diagnosis: stage 4 metastatic triple-negative breast cancer. This subtype of breast cancer,...
AACR Shares Mission of World Cancer Day: Ending Disparities
World Cancer Day is February 4, 2023. This annual initiative by the Union for International Cancer Control (UICC) aims...
Personalized Neoantigen Vaccines Boost Progress Against Aggressive Cancers
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
Interfacing with the Future: Artificial Intelligence in Oncology
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.
What Is a Cancer Vaccine?
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
Ending Cancer Health Disparities Through Increased Collaboration
Despite tremendous progress against cancer in the past few decades, not all Americans have benefited equally from advances in...
NIH-AACR Cancer, Autoimmunity, and Immunology Conference: A Virtual, Multidisciplinary Forum on Immune-related Adverse Events
By Meghali Goswami Meghali Goswami is a PhD candidate in the George Washington University – National Institutes of Health Graduate Partnerships Program and is currently...
AACR Journal Editors Share “Must Read” Articles for March
While COVID-19 is at the center of medical news, important cancer research findings continue to be reported. As March...
AACR Virtual Annual Meeting I: The Promises and Challenges of Expanding the Use of Immune Checkpoint Inhibitors Through Combination Therapy
The cutting-edge scientific program for the AACR Virtual Annual Meeting I began Monday, April 27, with an Opening Clinical Plenary featuring...
AACR Virtual Annual Meeting I: Results Presented Provide Basis for FDA Decision to Approve Alternative Pembrolizumab Dosing Schedule
A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
AACR-Cancer Research UK Transatlantic Fellowships: Inaugural Recipients Announced
The strategic alliance between the American Association for Cancer Research (AACR) and Cancer Research UK (CRUK) includes support for...
Melanoma Awareness Month: Improving Treatment for an Aggressive Skin Cancer
The days are getting longer and warmer, and visions of beach trips, cookouts, and picnics occupy our minds. While this year’s summer will likely look different due to the ongoing COVID-19 pandemic, months...
New Journal Article Explores Equity in Academia
As the murders of George Floyd, Breonna Taylor, and others exposed racial inequities in America, many sectors of society...
Advances in Malignant Lymphoma Virtual Meeting: Stratifying Risk, Targeting Precursor Cells, Hacking the Epigenome, and More
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent...
CRISPR in the Clinic: T-cell Genetic Engineering for Solid Tumors
Guest post by Emil Lou, MD, PhD On October 7, 2020, the world awoke to news that the Royal...
SABCS 2020: Exploring Safe De-escalation of Breast Cancer Treatment
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
What Biden’s Presidency Will Mean for Cancer Research
Editor’s note: As President Joseph R. Biden Jr. took office on Wednesday, Cancer Discovery, a journal of the American...
Addressing Racial Disparities in Multiple Myeloma Clinical Trials and Outcomes During the Pandemic
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
AACR Annual Meeting 2021: NCI Director Ned Sharpless Outlines Blueprint for Progress
With President Joseph R. Biden in the White House, the United States may be poised to make a major...
AACR Meetings Feature Latest Advances in Blood Cancer Research
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells...
AACR Annual Meeting 2021: A Recap of Blog Posts
The AACR Annual Meeting 2021 featured the theme “Discovery Science Driving Clinical Breakthroughs.” Indeed, over the course of two weeks,...
AACR Dialogues Spark Important Conversations About Cancer
In the ongoing quest to end cancer health disparities, there’s a simple tool that virtually anyone can use: honest...